<?xml version="1.0"?>
<Articles JournalTitle="Case Reports in Clinical Practice">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Case Reports in Clinical Practice</JournalTitle>
      <Issn>2538-2683</Issn>
      <Volume>10</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2025</Year>
        <Month>10</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">A Rare Heteroplasmic MT-ND5 Mutation (m.13094T&gt;C) in an Iranian Patient with Adult-Onset MELAS: Diagnostic Challenges and Therapeutic Implications</title>
    <FirstPage>83</FirstPage>
    <LastPage>89</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Hamed</FirstName>
        <LastName>Amirifard</LastName>
        <affiliation locale="en_US">Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mojtaba</FirstName>
        <LastName>Shahbazi</LastName>
        <affiliation locale="en_US">Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Ghasem</FirstName>
        <LastName>Farahmand</LastName>
        <affiliation locale="en_US">Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Maryam</FirstName>
        <LastName>Kaeedi</LastName>
        <affiliation locale="en_US">Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Sanaz</FirstName>
        <LastName>Heydari Havadaragh</LastName>
        <affiliation locale="en_US">Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2025</Year>
        <Month>07</Month>
        <Day>30</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2025</Year>
        <Month>09</Month>
        <Day>08</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes [MELAS] is a rare multisystem mitochondrial cytopathy that is highly heterogeneous in severity and clinical presentation, mostly caused by diverse mutations in the mitochondrial DNA. While m.3243A&gt;G is the most common variant, rare mutations like m.13094T&gt;C in MT-ND5 are increasingly recognized but poorly characterized. This report documents the case of a 37-year-old Iranian woman diagnosed with MELAS. Her clinical manifestations include recurrent episodes of stroke-like events, focal seizures, and elevated serum and CSF lactate. Mitochondrial DNA analysis [mtDNA] was positive for a very rare pathogenic point mutation [mtDNA; m.3243A&gt;G] in the MT-ND5 gene, with a heteroplasmy level of 8.2%. This case highlights: 1. Adult-onset MELAS with MT-ND5 mutations is underdiagnosed. 2.Low heteroplasmy (8.2%) may still cause severe phenotypes, suggesting tissuespecific effects. 3.Ethnic diversity in mtDNA mutations warrants broader genetic screening in non-classical cases.</abstract>
    <web_url>https://crcp.tums.ac.ir/index.php/crcp/article/view/1083</web_url>
    <pdf_url>https://crcp.tums.ac.ir/index.php/crcp/article/download/1083/723</pdf_url>
  </Article>
</Articles>
